Wound pH-Modulating Strategies for Diabetic Wound Healing
Advances in Wound Care · 01.09.2024 · 13 (9) · 446-462
DOI: 10.1089/wound.2023.0129 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Wound Care, erschienen am 01.09.2024. Verfasst von Léo-Paul Tricou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Pharmacie, Université de Montréal, Montréal, Canada. Hauptthemen laut MEDLINE: Wound Healing, Diabetic Foot. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Wundversorgung
Abstract (Originalsprache)
Significance: Chronic diabetic wounds on the lower extremities (diabetic foot ulcers, DFU) are one of the most prevalent and life-threatening complications of diabetes, responsible for significant loss of quality of life and cost to the health care system. Available pharmacologic treatments fail to achieve complete healing in many patients. Recent studies and investigational treatments have highlighted the potential of modulating wound pH in DFU. Recent Advances: Data from in vitro, preclinical, and clinical studies highlight the role of pH in the pathophysiology of DFU, and topical administration of pH-lowering agents have shown promise as a therapeutic strategy for diabetic wounds. In this critical review, we describe the role of pH in DFU pathophysiology and present selected low-molecular-weight and hydrogel-based pH-modulating systems for wound healing and infection control in diabetic wounds. Critical Issues: The molecular mechanisms leading to pH alterations in diabetic wounds are complex and may differ between in vitro models, animal models of diabetes, and the human pathophysiology. Wound pH-lowering bandages for DFU therapy must be tested in established animal models of diabetic wound healing and patients with diabetes to establish a comprehensive benefit-risk profile. Future Directions: As our understanding of the role of pH in the pathophysiology of diabetic wounds is deepening, new treatments for this therapeutic target are being developed and will be tested in preclinical and clinical studies. These therapeutic systems will establish a target product profile for pH-lowering treatments such as an optimal pH profile for each wound healing stage. Thus, controlling wound bed pH could become a powerful tool to accelerate chronic diabetic wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculté de Pharmacie, Université de Montréal, Montréal, Canada.
- ISPB Faculté de Pharmacie, Université Claude Bernard Lyon 1, Lyon, France.
- Chemical Engineering Department, Polytechnique Montreal, Montréal, Canada.
- Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Simon Matoori
Förderung
- NIA NIH HHS
Zitieren
APA
Tricou, L. P., Al-Hawat, M. L., Cherifi, K., Manrique, G., Freedman, B. R., & Matoori, S. (2024). Wound pH-Modulating Strategies for Diabetic Wound Healing. Advances in Wound Care, 13(9), 446-462. https://doi.org/10.1089/wound.2023.0129
Vancouver
Tricou LP, Al-Hawat ML, Cherifi K, Manrique G, Freedman BR, Matoori S. Wound pH-Modulating Strategies for Diabetic Wound Healing. Advances in Wound Care. 2024;13(9):446-462. doi:10.1089/wound.2023.0129
BibTeX
@article{Tricou2024,
author = {Tricou, Léo-Paul and Al-Hawat, Marie-Lynn and Cherifi, Katia and Manrique, Gabriela and Freedman, Benjamin R and Matoori, Simon},
title = {Wound pH-Modulating Strategies for Diabetic Wound Healing},
journal = {Advances in Wound Care},
year = {2024},
volume = {13},
number = {9},
pages = {446--462},
doi = {10.1089/wound.2023.0129}
}
EUVIMED